Back to search
FDAFDA · Food and drugs·Recall number D-0109-2021

Levetiracetam Tablets, USP 500 mg, packaged in 120-count bottle, Rx only, Manufactured by: VKT Pharma Private Limited Srikakulam, India - 532 409, Manufactured for: Eywa Pharma Inc. 2 Research Way, Floor 3 Princeton, NJ 08540, NDC 71930-063-52

Published December 2, 2020 · Recall initiated: November 10, 2020

Summary

FDA records drug Class II recall D-0109-2021, published December 2, 2020 and initiated November 10, 2020. Recalling firm: EYWA PHARMA INC; Status: Terminated; Reported quantity: 5451 bottles; Lot: Lot #: LEV5019021A, Exp 10/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of foreign tablet/capsule: A 1000 mg Levetiracetam Tablet was found in 500 gram bottle of Levetiracetam Tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
EYWA PHARMA INC
Distributor
USA Nationwide
Lot
Lot #: LEV5019021A, Exp 10/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Levetiracetam Tablets, USP 500 mg, packaged in 120-count bottle, Rx only, Manufactured by: VKT Pharma Private Limited Srikakulam, India - 532 409, Manufactured for: Eywa Pharma Inc. 2 Research Way, Floor 3 Princeton, NJ 08540, NDC 71930-063-52 recalled?

Yes. FDA published recall D-0109-2021 on December 2, 2020. Reported hazard: Presence of foreign tablet/capsule: A 1000 mg Levetiracetam Tablet was found in 500 gram bottle of Levetiracetam Tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter